Biomedical Engineering Reference
In-Depth Information
Gopinath, P., Gogoi, S.K., Sanpui, P., Paul, A., Chattopadhyay, A., and Ghosh, S.S. 2010. Signaling gene cas-
cade in silver nanoparticle induced apoptosis.
Colloids Surf B
77(2):240-245.
Gratton, S.E., Ropp, P.A., Pohlhaus, P.D. et al. 2008. The effect of particle design on cellular internalization
pathways.
Proc Natl Acad Sci USA
105:11613-11618.
Haraldsson, B., Nyström, J., and Deen, W.M. 2008. Properties of the glomerular barrier and mechanisms of
proteinuria.
Physiol Rev
88:451-487.
Harashima, H., Sakata, K., Funato, K., and Kiwada, H. 1994. Enhanced hepatic uptake of liposomes through
complement activation depending on the size of the liposomes.
Pharm Res
11:402-406.
Hardman, R. 2006. A toxicologic review of quantum dots: Toxicity depends on physicochemical and environ-
mental factors.
Environ Health Perspect
114:165-172.
Harris, M.J. and Chess, R.B. 2003. Effect of pegylation of pharmaceuticals.
Nat Rev Drug Discov
2:214-221.
Helinor, J.J., Gary, R.H., Frans, M.C., Karin, A., and Vicki, S. 2010. The biological mechanisms and physico-
chemical characteristics responsible for driving fullerene toxicity.
Toxicol Sci
114:162-182.
Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L., and Korsmeyer, S.J. 1993. Bcl-2 functions in an
antioxidant pathway to prevent apoptosis.
Cell
75:241-251.
Hsin, Y.H., Chen, C.F., Huang, S., Shih, T.S., Lai, P.S., and Chueh, P.J. 2008. The apoptotic effect of nanosilver
is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3
cells.
Toxicol Lett
179(3):130-139.
Hussain, N., Jaitley, V., and Florence, A.T. 2001. Recent advances in the understanding of uptake of micropar-
ticulate across the gastrointestinal lymphatics.
Adv Drug Delivery Rev
50:107-142.
Hussain, S. M., Hess, K. L., Gearhart, J. M., Geiss, K. T., and Schlager, J. J. 2005.
In vitro
toxicity of nanopar-
ticles in BRL 3A rat liver cells.
Toxicol In Vitro
19(7):975-983.
Isabelle, P., Marie, M., Marine, R., Igor, P., and Béatrice, L.A. 2012. Implication of oxidative stress in size-
dependent toxicity of silica nanoparticles in kidney cells.
Toxicology
299:112-124.
Ishida, T., Atobe, K., Wang, X.Y., and Kiwada, H. 2006. Accelerated blood clearance of PEGylated liposomes
upon repeated injections: Effect of doxorubicin encapsulation and high dose first injection.
J Control
Release
115:251-258.
Ishida, T., Harada, M., Wang, X.Y., Ichihara, M., Irimura, K., and Kiwada, H. 2005. Accelerated blood clear-
ance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG
surface-density and chain length of the first-dose liposomes.
J Control Release
105:305-317.
Ishida, T., Ichikawa, T., Ichihara, M., Sadsuka, Y., and Kiwada, H. 2004. Effect of physicochemical properties
of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice.
J Control Release
95:403-412.
Ishihara, T., Takeda, M., and Sakamoto, H. 2009. Accelerated blood clearance phenomenon upon repeated
injection of PEG-modified PLA nanoparticles,
Pharm Res
26:2270-2279.
Jacobs, F., Wisse, E., and De Geest, B. 2010. The role of the sinusoidal cells in hepatocyte directed gene trans-
fer.
Am J Pathol
176:14-21.
Jiang, W., Kim, B.Y., Rutka, J.T., and Chan, W.C. 2008. Nanoparticle-mediated cellular response is size-depen-
dent.
Nat Nanotechnol
3:145-150.
Jong, W.H.D., Hagens, W.I., Krystek, P., Burger, M.C., Sips, A.J.A.M., and Geertsma, R.E. 2008. Particle
size-dependent organ distribution of gold nanoparticles after intravenous administration.
Biomaterials
29:1912-1919.
Judge, A., McClintock, K., Phelps, J.R., and MacLachlan, I. 2006. Hypersensitivity and loss of disease site
targeting caused by antibody responses to PEGylated liposomes.
Mol Ther
13:328-337.
Kandasamy, K., Srinivasula, S.M., Alnemri, E.S. et al. 2003. Involvement of proapoptotic molecules Bax and
Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)—Induced mitochondrial dis-
ruption and apoptosis: Differential regulation of cytochrome c and Smac/DIABLO release.
Cancer Res
63:1712-1721.
Kawata, K., Osawa, M., and Okabe, S. 2009.
In vitro
toxicity of silver nanoparticles at noncytotoxic doses to
HepG2 human hepatoma cells.
Environ Sci Technol
43(15):6046-6051.
Khandoga, A., Stampfl, A., and Takenaka, S. 2004. Ultrafine particles exert prothrombotic but not inflammatory
effects on the hepatic microcirculation in healthy mice
in vivo
.
Circulation
109:1320-1325.
Kopecek, J., Kopeckova-Rejmanova, P., Minko, T., Lu, Z.R., and Peterson, C.M. 2001. Water soluble polymers
in tumor targeted delivery.
J Control Release
74:147-158.
Kostarelos, K., Lacerda, L., and Pastorin, G. 2007. Functionalized carbon nanotube cellular uptake and inter-
nalisation mechanism is independent of functional group and cell type.
Nat Nanotechnol
2:108-113.
Kumar, V., Abbas, A., Nelson, F., and Mitchell, R. 2007. Robbins basic pathology.
Robbins Basic Pathol
6:9-10.